Source: Health Products and Food Branch (CA) Revision Year: 2019
KIDROLASE (L-asparaginase) - 10,000 IU/Vial.
Powder for Solution for Intramuscular injection or Intravenous infusion.
Table 1. Dosage Forms, Strengths, Composition:
| Route of Administration | Dosage Form/Strength/Composition | Non-medicinal Ingredients |
|---|---|---|
| Intramuscular injection OR Intravenous infusion | Powder for Solution 10,000 IU Escherichia coli L-asparaginase per vial | Glycine Sodium hydroxide (for pH adjustment) |
The product contains no preservatives.
7 mL colourless glass vial made from Type II glass closed with a bromobutyl stopper and crimped with an aluminium cap stopper.
Pack size: 1 vial per carton.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Jazz Pharmaceuticals France SAS, 69006 Lyon, France 227233 |
Date of approval:
December 31, 1974 August 12, 2019 |
| Drug | Countries | |
|---|---|---|
| KIDROLASE | Canada, France |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
